American Healthcare REIT
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$50.48
FAIR PRICE
$34.26
MARGIN
$16.22
NOW AVAILABLE
Get notified when AHR's fair price changes
Push notifications when AHR's valuation shifts. Available on iOS and Android.
FPI RATING
High-quality fundamentals, but expensive valuation relative to fundamentals.
Analytical data, not an investment recommendation. Updated daily.
How we calculate this ↗MARGIN OF SAFETY
A 20% margin of safety below fair value — the conservative entry level for risk-aware investors.
SAFETY MARGIN
20%
Below fair value
ENTRY LEVEL
$27.41
Fair price × 0.80
DISTANCE
45.7%
Price to entry level
At the current price of $50.48, AHR trades 45.7% above the conservative entry level of $27.41. This entry level represents a 20% margin of safety below the calculated fair price of $34.26 — a buffer that accounts for estimation uncertainty in the valuation model.
Margin of safety is a risk management concept, not an investment recommendation. The 20% threshold follows Benjamin Graham's value investing framework. Fair price and entry levels are model-based estimates updated daily. Learn more about Margin of Safety ↗
VALUATION HISTORY
Loading chart data...
P/E RATIO HISTORY
Loading chart data...
METHODOLOGY
How we calculate AHR's fair price
American Healthcare REIT's fair price of $34.26 is derived from a blended model that combines DCF analysis (50%), relative valuation against Real Estate peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $50.48, AHR trades 32.1% above its calculated fair value.
DCF MODEL · 50%
Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting AHR's risk profile.
RELATIVE · 30%
Comparing AHR's valuation multiples against Real Estate peers to determine if the stock is over or undervalued relative to its industry.
ANALYST · 20%
Aggregated analyst price targets for AHR, weighted by recency and analyst accuracy.
TRY IT YOURSELF
Want to test your own assumptions? Use our free calculators to estimate AHR's fair value with your own inputs.
LEARN MORE
POWERED BY BULIOS
Get full analysis, financials, and AI insights for AHR.
Explore on BuliosFAQ
What is the fair price of AHR?+
Based on our blended model combining DCF analysis (50%), relative valuation against Real Estate peers (30%), and analyst consensus (20%), the fair price for American Healthcare REIT is $34.26. At the current market price of $50.48, AHR trades 32.1% above its calculated fair value.
Is AHR overvalued or undervalued?+
American Healthcare REIT is currently overvalued based on our valuation model. The stock trades at $50.48, which is 32.1% above the fair price of $34.26. The P/E ratio of 124.7x is a key metric in the valuation.
What is the margin of safety for AHR?+
With a 20% margin of safety applied to the fair price of $34.26, the conservative entry level for AHR is $27.41. At the current market price of $50.48, the stock trades 45.7% above this entry level. Margin of safety is a risk management concept from Benjamin Graham's value investing framework, not an investment recommendation.
How often is AHR's fair price updated?+
We update fair price calculations for AHR daily after market close. The current fair price of $34.26 incorporates the latest market data and sector multiples.
What factors affect AHR's fair price calculation?+
AHR's fair price of $34.26 is derived from DCF analysis (50% weight), relative valuation against Real Estate peers (30% weight), and analyst consensus (20% weight). Key metrics include P/E of 124.7x, ROE of 2901.7%, and dividend yield of 1.99%.
Is AHR a good buy right now?+
At $50.48, AHR trades 32.1% above our fair value estimate of $34.26. The stock is currently overvalued. ROE stands at 2901.7% (exceptional). Fair Price Index provides valuation data — always do your own research before investing.
Does AHR pay dividends?+
AHR has a dividend yield of 1.99%.
RELATED STOCKS
Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.